INTERMEDIATE AGE-RELATED MACULAR DEGENERATION
Clinical trials for INTERMEDIATE AGE-RELATED MACULAR DEGENERATION explained in plain language.
Never miss a new study
Get alerted when new INTERMEDIATE AGE-RELATED MACULAR DEGENERATION trials appear
Sign up with your email to follow new studies for INTERMEDIATE AGE-RELATED MACULAR DEGENERATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a herbal granule slow down a leading cause of vision loss?
Disease control Recruiting nowThis study tests whether QA108 granules can help people with intermediate age-related macular degeneration (AMD), an eye condition that can lead to vision loss. The trial involves 400 adults aged 45-85 who have large drusen (yellow deposits) in the eye. Participants will receive …
Matched conditions: INTERMEDIATE AGE-RELATED MACULAR DEGENERATION
Phase: PHASE3 • Sponsor: Smilebiotek Zhuhai Limited • Aim: Disease control
Last updated May 10, 2026 11:54 UTC
-
Eggs on the menu: a new hope for eye health?
Disease control Recruiting nowThis small early-phase study is testing whether older adults with intermediate age-related macular degeneration (AMD) can stick to eating 2 or 4 whole eggs daily for 5 months. The goal is to see if this is a practical approach for a future larger trial that could explore how eggs…
Matched conditions: INTERMEDIATE AGE-RELATED MACULAR DEGENERATION
Phase: EARLY_PHASE1 • Sponsor: Kathryn Starr • Aim: Disease control
Last updated May 07, 2026 18:41 UTC